Results 1 to 10 of about 435,710 (236)

Emerging phagocytosis checkpoints in cancer immunotherapy

open access: yesSignal Transduction and Targeted Therapy, 2023
Cancer immunotherapy, mainly including immune checkpoints-targeted therapy and the adoptive transfer of engineered immune cells, has revolutionized the oncology landscape as it utilizes patients’ own immune systems in combating the cancer cells.
Qi Wu, Yufeng Shi
exaly   +2 more sources

Phagocytosis: Our Current Understanding of a Universal Biological Process

open access: yesFrontiers in Immunology, 2020
Phagocytosis is a cellular process for ingesting and eliminating particles larger than 0.5 μm in diameter, including microorganisms, foreign substances, and apoptotic cells.
Eileen Uribe-Querol, Carlos Rosales
doaj   +2 more sources

Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance

open access: yesCancer Cell, 2021
Immunotherapy induces durable clinical responses in a fraction of patients with cancer. However, therapeutic resistance poses a major challenge to current immunotherapies.
Heng Lin, Ilona Kryczek, Michael D Green
exaly   +2 more sources

Syk activation during FcγR-mediated phagocytosis involves Syk palmitoylation and desulfenylation [PDF]

open access: yesLife Science Alliance
Upon Fc gamma R–mediated phagocytosis, Syk is palmitoylated by DHHC5 and desulfenylated on nearby Cys residues, and both modifications are important for Syk phosphorylation and phagocytosis.
Maxime Jansen   +4 more
doaj   +2 more sources

Phagocytosis in the Brain: Homeostasis and Disease

open access: yesFrontiers in Immunology, 2019
Microglia are resident macrophages of the central nervous system and significantly contribute to overall brain function by participating in phagocytosis during development, homeostasis, and diseased states.
Dylan A. Galloway   +3 more
doaj   +2 more sources

LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance

open access: yesCell, 2018
Targeting autophagy in cancer cells and in the tumor microenvironment are current goals of cancer therapy. However, components of canonical autophagy play roles in other biological processes, adding complexity to this goal.
Larissa D Cunha   +2 more
exaly   +2 more sources

Phagocytosis checkpoints as new targets for cancer immunotherapy

open access: yesNature Reviews Cancer, 2019
Mingye Feng, Wen Jiang, Betty Y S Kim
exaly   +2 more sources

Phagocytosis [PDF]

open access: yesCurrent Biology, 2011
SummaryPhagocytosis is defined as the receptor-mediated engulfment of large (≥0.5 μm) particles into plasma membrane-derived vacuoles called phagosomes. Following scission from the plasma membrane, the phagosomes undergo a maturation process, sequentially fusing with endosomes and lysosomes, ultimately becoming phagolysosomes — highly acidic and ...
Botelho, Roberto J., Grinstein, Sergio
  +5 more sources

Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity

open access: yesCell Reports, 2021
Summary: Blockade of the inhibitory checkpoint SIRPα-CD47 promotes phagocytosis of cancer cells by macrophages and is a promising avenue in anti-cancer therapy.
Zhenghai Tang   +6 more
doaj   +1 more source

Beyond autophagy: LC3-associated phagocytosis and endocytosis

open access: yesScience Advances, 2022
Noncanonical functions of the autophagy machinery in pathways including LC3-associated phagocytosis and LC3-associated endocytosis have garnered increasing interest in both normal physiology and pathobiology.
C. Peña-Martínez   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy